-transparent.png){kind=logo}
Autoradiography (3H-thymidine) and DNA-cytofluorometry were used to study the effect of quinoline dibromide (QD), a potential inhibitor of cobalamine-dependent methionine synthetase, on the kinetics of cell proliferation of L-1210 mouse leukemia. QD was found to produce the secondary blockade of leukemic cells in the late S-phase of the mitotic cycle. Such a mechanism of QD action promoted the potentiation of antitumor activity of the antimetabolites methotrexate, cytosine arabinoside and 5-fluorouracil during combined chemotherapy.
Related Publications
O D Golenko, and
T D Paramonova, and
T G Nikolaeva
January 1955,
Revue d'hematologie,
O D Golenko, and
T D Paramonova, and
T G Nikolaeva
January 1972,
Residue reviews,
O D Golenko, and
T D Paramonova, and
T G Nikolaeva
September 1982,
Cancer treatment reports,
O D Golenko, and
T D Paramonova, and
T G Nikolaeva
May 1996,
[Rinsho ketsueki] The Japanese journal of clinical hematology,
O D Golenko, and
T D Paramonova, and
T G Nikolaeva
December 1980,
Nihon Ketsueki Gakkai zasshi : journal of Japan Haematological Society,
O D Golenko, and
T D Paramonova, and
T G Nikolaeva
June 1974,
Nihon Ketsueki Gakkai zasshi : journal of Japan Haematological Society,
O D Golenko, and
T D Paramonova, and
T G Nikolaeva
October 1976,
Journal of medicinal chemistry,
O D Golenko, and
T D Paramonova, and
T G Nikolaeva
January 1957,
Science (New York, N.Y.),
O D Golenko, and
T D Paramonova, and
T G Nikolaeva
May 1991,
Diabete & metabolisme,
O D Golenko, and
T D Paramonova, and
T G Nikolaeva
April 1950,
Comptes rendus des seances de la Societe de biologie et de ses filiales,
